Expert Providers of Cancer Patient Samples
Detecting, diagnosing and treating cancer earlier is a key aspect in decreasing cancer-related mortality. An estimated 15% of cancer-related deaths could be prevented if they were diagnosed at stage III rather than stage IV, highlighting the need for improved cancer diagnostic tests. We specialise in providing cancer serum, plasma and tissue specimens and understand the importance of annotated biological samples for your research.
Disease Staged Cancer Tissue and Biofluids
We offer a wide selection of serum and plasma markers including CA125, CA15-3, CA72-4, Cyfra21-1 and SCLC, and an extensive range of FFPE/ Frozen tissue including Breast, Colon and Liver. Our samples are accompanied by detailed documentation and ethically collected.
- Pre-treatment donor samples
- Confirmed diagnosis
- Test method and analyte concentration provided
- Bulk serum and plasma available for some markers
Prospective Collection Project Examples
Pre-treatment, Diseased Staged Cancer Serum
Marker: Small Cell Lung Carcinoma (SCLC)
Number of lots: 120 donors
Matrix: Serum
Volume per lot: 5 x 1ml aliquots from each donor
Specification: Pre-treatment donors, no freeze-thaw cycles
Donor information: SCLC Disease-stage recorded, age, gender, date of collection, ethnicity
Cyfra-21-1 Remnant samples collection
Markers: Cyfra 21-1
Number of lots: 300 donors
Matrix: Serum
Test Performed: Fujirebio CanAg Cyfra 21-1 EIA (ng/mL)
Volume per lot: 0.5 ml from each donor
Specification: Variable titres ranging 4-90 ng/mL
Donor information: Date of collection, titre
Search Our Products
Related Logical Insights Blog
)